ClinicalTrials.Veeva

Menu

Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty (SUPER-DMEK)

U

University Eye Hospital, Freiburg

Status

Completed

Conditions

Fuchs' Endothelial Dystrophy

Treatments

Behavioral: Supine positioning: 1 days
Behavioral: Supine positioning: 5 days

Study type

Interventional

Funder types

Other

Identifiers

NCT05399095
ETK 22-1101

Details and patient eligibility

About

This randomized controlled trial evaluates the efficacy and safety of postoperative supine head positioning on graft attachment after Descemet membrane endothelial keratoplasty in patients with Fuchs' endothelial corneal dystrophy (FECD).

Full description

In Descemet membrane endothelial keratoplasty (DMEK), an air or gas bubble is inserted in the anterior chamber of the eye to keep the ultrathin endothelial corneal graft attached to the patients own cornea. Supine positioning is thought to improve attachment by using the tamponade effect of the bubble. At present, it is unclear how long supine positioning is required. Positioning regimens vary between one hour to over one week. In this trial, the investigators will assess if prolonged supine positioning for 5 days improves graft attachment and long-term outcomes compared to supine positioning for 1 day.

Enrollment

90 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of advanced Fuchs' endothelial corneal dystrophy (FECD)
  • Indication for corneal endothelial transplantation (Descemet Membrane Endothelial Keratoplasty - DMEK)

Exclusion criteria

  • Other corneal diseases (i.e. corneal scars, corneal dystrophies except FECD, corneal inflammation / infection)
  • Regular use of drugs potentially affecting the cornea (i.e. amiodarone, chloroquine, triptan, isotretinoin, use of contact lenses in past four weeks, anesthetic eye drops)
  • Diabetes mellitus with endorgan complications)
  • Lack of fixation during corneal tomography
  • Bedridden

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

90 participants in 2 patient groups

5 days supine positioning
Experimental group
Description:
Supine positioning for 5 days after DMEK with upright positioning for only 10 min every hour.
Treatment:
Behavioral: Supine positioning: 5 days
1 day supine positioning followed by usual physical activity for 4 days
Active Comparator group
Description:
Supine positioning for 1 days after DMEK with upright positioning for only 10 min every hour.
Treatment:
Behavioral: Supine positioning: 1 days

Trial contacts and locations

1

Loading...

Central trial contact

Dr. Anne-Marie Shirley Kladny, MD; PD Dr. Katrin Wacker, MD FEBO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems